Archive | August, 2011

August 2011 Life Science Market Review:Winners and Losers

Worse August in a Decade Down 6%-Economic Data Still Foreboding and Macro Headwinds Remain If you were on vacation for the month of August and reviewed your “balanced” portfolio today you might wonder what everyone was freaking out about. Treasuries were up big. The DOW just turned positive for the year and the NASDAQ is […]

Continue Reading 0

Stealth Rally Continues Despite Weak Economic Forecasts: Life Science Stocks Up Over 2.5%

Personalized Medicine Achieves Milestone with Lung Cancer Drug Friday’s rally picked up steam today as devastation from Hurricane Irene was less than expected and consumer spending was up. Greek stocks also rallied on a bank merger. Why are Greek stocks boosting this market? NASDAQ and the S&P were up more than 2%. Our favorite trading […]

Continue Reading 0

Stocks Rally as Fed Shifts to Idle: Biotechs Strong ILMN, SGEN

Can Congress Ignore a 78% Disapproval Rating? All the anticipation of the FED and Jackson Hole went to the ZEN mode-do nothing and the market will rally. Investors apparently were interpreting this as the economy isn’t bad enough to warrant stimulus. Around 10:25am today NASDAQ went into an upside reversal after being down 1%, surged […]

Continue Reading 0

Risk Off: Day Traders and Robots Rule

A day before the Bernanke addresses the public on potential FED plans and the state of the economy the market reverted back to the Euro Debt crisis selling tracking the European stocks decline. The market major indices sold off 1.5% while the FTSE-100 was off 1.44%. NASDAQ was off 1.95%. The leading sector was materials […]

Continue Reading 0

Three Days of Market Gains: Biotechnology Trades Are Holding

Drug Stocks with Dividends for Safety and Appreciation On Monday AM we thought blue chip drug and biotech stocks were poised to rally and we were rewarded. The S&P has come back to early August depressed levels but we have a double bottom in August. Healthcare overall was up 0.53% today compared to 1.3%  for […]

Continue Reading 0

Global Recession Fears Dominate Market: Safety in Biotechnology and Large Cap Drug Stocks

Got Gold and U.S. Treasuries? It is impossible to really describe the market turmoil in the space below so let this post from Investor Uprising suffice. With 10 Year treasuries under 2% and Gold approaching $1900 fear is pervasive. Bankers meet in Jackson Hole next week and we will hear more about the European debt […]

Continue Reading 0

Sell-Off Resumes as European Debt Crisis Gets Headlines

No Eurobond and Possible Financial Transaction Tax NASDAQ down 0.9% % and S&P down 0.7 % as Bear Returns but Off Session Lows Earlier in Trading The three day stock market rally is on hold for now as the global debt crisis hits home again. Gold is poised to close at all time high of […]

Continue Reading 0

Q2 Review of Pure Play Diagnostic Companies:Bargain Hunting in ABAX,GPRO,QGEN

Summary of Q2 Earnings and Valuation Metrics of Selected Pure Play Dx Companies Company Ticker Price RevEst Q1Rev Q2Rev Price Mcap P/S PE PEG 5/18/11 $M Yr. $M 15-Aug $M GenProbe GPRO 80 579 143 136 60 2900 5 29 2 Abaxis ABAX 28 157 37.5 36 23.9 544 3.46 41 2.3 Alere ALR 2360 […]

Continue Reading 0

Eurozone Crisis Creates More Fear and a Vicious Sell-Off

Global Debt Crisis Weighs In-Everything is Interconnected Panic selling has eased after European market closes but we are still down 3%. 10 Year treasuries are under 2.5%.Banks cannot handle the flow of money to safety and may actually charge for opening an account. Gold is selling off $1654 down $6.60 on rumors of a margin […]

Continue Reading 0

Wild Turnaround Day- RoboTraders Again?

Time to Follow the Technicals If you missed the morning action today you were better off unless you were bargain hunting. It looked like another ugly free-fall day at about 10 am EDT until some trigger set off buying with a lot of  choppiness but then volume picked up at 1:30 pm and the market […]

Continue Reading 0